JP2018529770A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529770A5
JP2018529770A5 JP2018535238A JP2018535238A JP2018529770A5 JP 2018529770 A5 JP2018529770 A5 JP 2018529770A5 JP 2018535238 A JP2018535238 A JP 2018535238A JP 2018535238 A JP2018535238 A JP 2018535238A JP 2018529770 A5 JP2018529770 A5 JP 2018529770A5
Authority
JP
Japan
Prior art keywords
methyl
amino
indol
pyrazol
propanamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018535238A
Other languages
English (en)
Japanese (ja)
Other versions
JP6767491B2 (ja
JP2018529770A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/072616 external-priority patent/WO2017050938A1/en
Publication of JP2018529770A publication Critical patent/JP2018529770A/ja
Publication of JP2018529770A5 publication Critical patent/JP2018529770A5/ja
Application granted granted Critical
Publication of JP6767491B2 publication Critical patent/JP6767491B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018535238A 2015-09-25 2016-09-22 Jakを阻害するための化合物及び方法 Active JP6767491B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562232629P 2015-09-25 2015-09-25
US62/232,629 2015-09-25
PCT/EP2016/072616 WO2017050938A1 (en) 2015-09-25 2016-09-22 Compounds and methods for inhibiting jak

Publications (3)

Publication Number Publication Date
JP2018529770A JP2018529770A (ja) 2018-10-11
JP2018529770A5 true JP2018529770A5 (https=) 2020-01-23
JP6767491B2 JP6767491B2 (ja) 2020-10-14

Family

ID=56979589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018535238A Active JP6767491B2 (ja) 2015-09-25 2016-09-22 Jakを阻害するための化合物及び方法

Country Status (17)

Country Link
US (5) US9714236B2 (https=)
EP (2) EP4219482A1 (https=)
JP (1) JP6767491B2 (https=)
KR (2) KR20250035597A (https=)
CN (4) CN111606893B (https=)
AR (1) AR106138A1 (https=)
AU (1) AU2016328764B2 (https=)
BR (1) BR112018005833B1 (https=)
CA (1) CA2995430C (https=)
DK (1) DK3353168T3 (https=)
ES (1) ES2956642T3 (https=)
MX (1) MX375724B (https=)
PT (1) PT3353168T (https=)
RU (1) RU2760359C2 (https=)
TW (1) TWI740843B (https=)
WO (1) WO2017050938A1 (https=)
ZA (1) ZA201800782B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6767491B2 (ja) * 2015-09-25 2020-10-14 ディザル(ジァンスー)ファーマシューティカル・カンパニー・リミテッド Jakを阻害するための化合物及び方法
MX383920B (es) 2016-05-26 2025-03-14 Recurium Ip Holdings Llc Compuestos inhibidores de egfr.
ES2938648T3 (es) * 2017-01-17 2023-04-13 Astrazeneca Ab Inhibidores selectivos de JAK1
KR20190043437A (ko) 2017-10-18 2019-04-26 씨제이헬스케어 주식회사 단백질 키나제 억제제로서의 헤테로고리 화합물
EP3823964A1 (en) * 2018-07-18 2021-05-26 Astrazeneca AB A xinafoate salt of a jak inhibiting compound
CA3113732C (en) * 2018-09-21 2023-07-11 Shanghai Ennovabio Pharmaceuticals Co., Ltd. Aromatic heterocyclic compound with kinase inhibitory activity
KR102195348B1 (ko) * 2018-11-15 2020-12-24 에이치케이이노엔 주식회사 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물
MX2021012749A (es) * 2019-04-19 2021-11-18 Dizal Jiangsu Pharmaceutical Co Ltd Inhibidor selectivo de la jak1 cinasa.
CN110627775B (zh) * 2019-10-24 2026-01-30 特科罗生物科技(成都)有限公司 一种小分子化合物
CN111961037B (zh) * 2020-09-17 2021-09-21 嘉兴特科罗生物科技有限公司 一种作为jak激酶抑制剂的药物化合物
WO2022111499A1 (zh) * 2020-11-26 2022-06-02 深圳铂立健医药有限公司 一种酰胺化合物、药物组合物及其应用
TW202246243A (zh) * 2021-02-26 2022-12-01 美商泰拉生物科學公司 胺基嘧啶化合物及其使用方法
MX2023010642A (es) 2021-03-11 2023-11-28 Janssen Pharmaceutica Nv Lorpucitinib para uso en el tratamiento de trastornos mediados por jak.
CN115260128B (zh) * 2022-09-21 2022-12-09 苏州凯瑞医药科技有限公司 一种新型jak抑制剂关键中间体的制备方法
WO2025230951A1 (en) * 2024-04-29 2025-11-06 Icahn School Of Medicine At Mount Sinai Method of treating adenoid cystic carcinoma

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364340T3 (es) * 2004-03-30 2011-08-31 Vertex Pharmaceuticals Incorporated Azaindoles útiles como inhibidores de jak y otras proteína quinasas.
GB0500492D0 (en) * 2005-01-11 2005-02-16 Cyclacel Ltd Compound
JP2009513615A (ja) 2005-10-28 2009-04-02 アストラゼネカ アクチボラグ 癌の治療においてチロシンキナーゼ阻害剤として使用するための4−(3−アミノピラゾール)ピリミジン誘導体
KR20080110998A (ko) * 2006-01-30 2008-12-22 엑셀리시스, 인코포레이티드 Jak­2 조절자로서 4­아릴­2­아미노­피리미딘 또는 4­아릴­2­아미노알킬­피리미딘 및 이들을 포함하는 약제학적 조성물
EA017405B9 (ru) * 2006-12-08 2014-05-30 АйАрЭм ЭлЭлСи Соединения и композиции в качестве ингибиторов протеинкиназы
US9908884B2 (en) * 2009-05-05 2018-03-06 Dana-Farber Cancer Institute, Inc. EGFR inhibitors and methods of treating disorders
AR076794A1 (es) 2009-05-22 2011-07-06 Incyte Corp Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
EP2611793A1 (en) * 2010-09-01 2013-07-10 Ambit Biosciences Corporation 2-cycloquinazoline derivatives and methods of use thereof
US9198911B2 (en) 2010-11-02 2015-12-01 The Trustees Of Columbia University In The City Of New York Methods for treating hair loss disorders
JP2014500254A (ja) * 2010-11-09 2014-01-09 セルゾーム リミティッド Tyk2阻害剤としてのピリジン化合物およびそのアザ類似体
PE20140146A1 (es) * 2010-11-19 2014-02-06 Incyte Corp Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
WO2012116247A1 (en) * 2011-02-25 2012-08-30 Synta Pharmaceuticals Corp. Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers
CN103797010B (zh) * 2011-06-20 2016-02-24 因塞特控股公司 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
DK2830662T3 (da) 2012-03-29 2019-01-02 Univ Columbia Fremgangsmåder til behandlng af hårtabsforstyrrelser
JP6767491B2 (ja) * 2015-09-25 2020-10-14 ディザル(ジァンスー)ファーマシューティカル・カンパニー・リミテッド Jakを阻害するための化合物及び方法

Similar Documents

Publication Publication Date Title
JP2018529770A5 (https=)
JP2022043059A5 (https=)
RU2018112993A (ru) Соединения и способы для ингибирования JAK
JP2020506171A5 (https=)
JP2017504635A5 (https=)
JP2013056930A5 (https=)
JP2013527202A5 (https=)
JP2016503786A5 (https=)
JP2014139226A5 (https=)
JP2014511891A5 (https=)
CA2601508A1 (en) Cyclopropanecarboxamide derivatives
JP2009513703A5 (https=)
JP2019505541A5 (https=)
JP2018507877A5 (https=)
JP2009526072A5 (https=)
NZ593594A (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
JP2017527578A5 (https=)
JP2013525318A5 (https=)
JP2013512899A5 (https=)
JP2008539268A5 (https=)
JP2010504344A5 (https=)
JP2008539267A5 (https=)
JP2009502743A5 (https=)
JP2022551973A5 (https=)
CN107635975B (zh) Dgat2抑制剂